The genes tested by the recently registered Roszdravnadzor (Roszdravnadzor’s Metabolic Kit 60) lifestyle test increase the risk of developing disease by 3-15% and therefore cannot be used to reliably predict health risks. This was told socialbites.ca by a doctor of biological sciences, head of the genome analysis laboratory of the Institute of General Genetics. NI Vavilov RAS Svetlana Borinskaya.
Test-controlled genes for optimal lifestyle increase the risk of developing the disease by 3%, sometimes 10-15%, but not several times. The geneticist noted that these are not genes that should be used for reliable prediction. But there are mutations associated with a significant increase in disease risk – these are worth checking.
“For example, it’s worth examining the BRCA gene, a mutation found in Angelina Jolie. In carriers of such a mutation, breast cancer begins 10-15 years earlier and develops 80% during their lifetime. This is really serious, that’s why this type of genetic analysis is used in medicine. There are gene variants that determine the rate at which drugs are metabolized. And therefore, such a drug as the anticoagulant “Warfarin” in the United States is prescribed taking into account genetic characteristics. The dose can change several times,” Borinsky explained.
ancient scientists to solvethat tumor genome analysis may be useful for only 5% of cancer patients, while in other cases it may reduce the chances of survival.